{"entity":{"type":"insider","cik":"0001722140","url":"/insider/0001722140","json_url":"/insider/0001722140.json","name":"Ceesay Abraham","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":42,"n_filings":15,"first":"2022-08-09","last":"2026-08-12","span_basis":"filed_date"},"name_variants":[{"name":"Ceesay Abraham","source":"filing","n_filings":15,"first_seen":"2022-08-09","last_seen":"2026-08-12"}],"transactions":[{"id":9255448,"accession":"0001193125-26-346995","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-346995","line_url":"/filing/0001193125-26-346995","is_derivative":false,"issuer_cik":"0001722140","issuer_name":"Rapport Therapeutics, Inc.","issuer_ticker":"RAPP","issuer_name_source":null,"issuer_url":"/issuer/0001722140","owner_cik":"0001722140","owner_name":"Ceesay Abraham","owner_display_name":"Ceesay Abraham","owner_url":"/insider/0001722140","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28958.0,"shares_display":"28,958","price_per_share":48.01452399336971,"price_display":"48.01","price_state":"stated","total_value":1390404.5858,"total_display":"1,390,404.59","total_whole":"1,390,405","shares_owned_after":491902.0,"shares_owned_after_display":"491,902","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-11","filed_date":"2026-08-12","scope":"insider","n_lines":3},{"id":9255447,"accession":"0001193125-26-346995","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-346995","line_url":"/filing/0001193125-26-346995","is_derivative":false,"issuer_cik":"0001722140","issuer_name":"Rapport Therapeutics, Inc.","issuer_ticker":"RAPP","issuer_name_source":null,"issuer_url":"/issuer/0001722140","owner_cik":"0001722140","owner_name":"Ceesay Abraham","owner_display_name":"Ceesay Abraham","owner_url":"/insider/0001722140","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22541.0,"shares_display":"22,541","price_per_share":46.26111568253405,"price_display":"46.26","price_state":"stated","total_value":1042771.8086,"total_display":"1,042,771.81","total_whole":"1,042,772","shares_owned_after":515066.0,"shares_owned_after_display":"515,066","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-10","filed_date":"2026-08-12","scope":"insider","n_lines":2},{"id":5920554,"accession":"0001193125-26-323637","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-323637","line_url":"/filing/0001193125-26-323637","is_derivative":false,"issuer_cik":"0001722140","issuer_name":"Rapport Therapeutics, Inc.","issuer_ticker":"RAPP","issuer_name_source":null,"issuer_url":"/issuer/0001722140","owner_cik":"0001722140","owner_name":"Ceesay Abraham","owner_display_name":"Ceesay Abraham","owner_url":"/insider/0001722140","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2210.0,"shares_display":"2,210","price_per_share":42.10898914027149,"price_display":"42.11","price_state":"stated","total_value":93060.866,"total_display":"93,060.87","total_whole":"93,061","shares_owned_after":537614.0,"shares_owned_after_display":"537,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-27","filed_date":"2026-07-29","scope":"insider","n_lines":2},{"id":5825796,"accession":"0001193125-26-304786","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-304786","line_url":"/filing/0001193125-26-304786","is_derivative":false,"issuer_cik":"0001722140","issuer_name":"Rapport Therapeutics, Inc.","issuer_ticker":"RAPP","issuer_name_source":null,"issuer_url":"/issuer/0001722140","owner_cik":"0001722140","owner_name":"Ceesay Abraham","owner_display_name":"Ceesay Abraham","owner_url":"/insider/0001722140","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8210.0,"shares_display":"8,210","price_per_share":40.00447226552984,"price_display":"40.00","price_state":"stated","total_value":328436.7173,"total_display":"328,436.72","total_whole":"328,437","shares_owned_after":542546.0,"shares_owned_after_display":"542,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-14","filed_date":"2026-07-15","scope":"insider","n_lines":2},{"id":5930539,"accession":"0001193125-26-292519","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-292519","line_url":"/filing/0001193125-26-292519","is_derivative":false,"issuer_cik":"0001722140","issuer_name":"Rapport Therapeutics, Inc.","issuer_ticker":"RAPP","issuer_name_source":null,"issuer_url":"/issuer/0001722140","owner_cik":"0001722140","owner_name":"Ceesay Abraham","owner_display_name":"Ceesay Abraham","owner_url":"/insider/0001722140","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8220.0,"shares_display":"8,220","price_per_share":39.82940598540146,"price_display":"39.83","price_state":"stated","total_value":327397.7172,"total_display":"327,397.72","total_whole":"327,398","shares_owned_after":548903.0,"shares_owned_after_display":"548,903","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-29","filed_date":"2026-07-01","scope":"insider","n_lines":2},{"id":5822357,"accession":"0001193125-26-059886","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-059886","line_url":"/filing/0001193125-26-059886","is_derivative":false,"issuer_cik":"0001722140","issuer_name":"Rapport Therapeutics, Inc.","issuer_ticker":"RAPP","issuer_name_source":null,"issuer_url":"/issuer/0001722140","owner_cik":"0001722140","owner_name":"Ceesay Abraham","owner_display_name":"Ceesay Abraham","owner_url":"/insider/0001722140","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10916.0,"shares_display":"10,916","price_per_share":29.34893755954562,"price_display":"29.35","price_state":"stated","total_value":320373.0024,"total_display":"320,373.00","total_whole":"320,373","shares_owned_after":558528.0,"shares_owned_after_display":"558,528","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-18","filed_date":"2026-02-19","scope":"insider","n_lines":4},{"id":5782076,"accession":"0001193125-26-019820","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-019820","line_url":"/filing/0001193125-26-019820","is_derivative":false,"issuer_cik":"0001722140","issuer_name":"Rapport Therapeutics, Inc.","issuer_ticker":"RAPP","issuer_name_source":null,"issuer_url":"/issuer/0001722140","owner_cik":"0001722140","owner_name":"Ceesay Abraham","owner_display_name":"Ceesay Abraham","owner_url":"/insider/0001722140","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10916.0,"shares_display":"10,916","price_per_share":26.114961835837303,"price_display":"26.11","price_state":"stated","total_value":285070.9234,"total_display":"285,070.92","total_whole":"285,071","shares_owned_after":562080.0,"shares_owned_after_display":"562,080","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-20","filed_date":"2026-01-22","scope":"insider","n_lines":2},{"id":4372913,"accession":"0001193125-25-324826","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193125-25-324826","line_url":"/filing/0001193125-25-324826","is_derivative":false,"issuer_cik":"0001722140","issuer_name":"Rapport Therapeutics, Inc.","issuer_ticker":"RAPP","issuer_name_source":null,"issuer_url":"/issuer/0001722140","owner_cik":"0001722140","owner_name":"Ceesay Abraham","owner_display_name":"Ceesay Abraham","owner_url":"/insider/0001722140","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10916.0,"shares_display":"10,916","price_per_share":29.63616096555515,"price_display":"29.64","price_state":"stated","total_value":323508.3331,"total_display":"323,508.33","total_whole":"323,508","shares_owned_after":568513.0,"shares_owned_after_display":"568,513","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-17","filed_date":"2025-12-18","scope":"insider","n_lines":6},{"id":4426290,"accession":"0001193125-25-286218","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-25-286218","line_url":"/filing/0001193125-25-286218","is_derivative":false,"issuer_cik":"0001722140","issuer_name":"Rapport Therapeutics, Inc.","issuer_ticker":"RAPP","issuer_name_source":null,"issuer_url":"/issuer/0001722140","owner_cik":"0001722140","owner_name":"Ceesay Abraham","owner_display_name":"Ceesay Abraham","owner_url":"/insider/0001722140","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10916.0,"shares_display":"10,916","price_per_share":25.196676200073288,"price_display":"25.20","price_state":"stated","total_value":275046.9174,"total_display":"275,046.92","total_whole":"275,047","shares_owned_after":573746.0,"shares_owned_after_display":"573,746","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-11-18","scope":"insider","n_lines":4},{"id":4202128,"accession":"0001193125-25-241472","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-25-241472","line_url":"/filing/0001193125-25-241472","is_derivative":false,"issuer_cik":"0001722140","issuer_name":"Rapport Therapeutics, Inc.","issuer_ticker":"RAPP","issuer_name_source":null,"issuer_url":"/issuer/0001722140","owner_cik":"0001722140","owner_name":"Ceesay Abraham","owner_display_name":"Ceesay Abraham","owner_url":"/insider/0001722140","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10916.0,"shares_display":"10,916","price_per_share":25.808825824477832,"price_display":"25.81","price_state":"stated","total_value":281729.1427,"total_display":"281,729.14","total_whole":"281,729","shares_owned_after":580765.0,"shares_owned_after_display":"580,765","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-15","filed_date":"2025-10-16","scope":"insider","n_lines":4},{"id":4795589,"accession":"0001193125-25-209062","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-25-209062","line_url":"/filing/0001193125-25-209062","is_derivative":false,"issuer_cik":"0001722140","issuer_name":"Rapport Therapeutics, Inc.","issuer_ticker":"RAPP","issuer_name_source":null,"issuer_url":"/issuer/0001722140","owner_cik":"0001722140","owner_name":"Ceesay Abraham","owner_display_name":"Ceesay Abraham","owner_url":"/insider/0001722140","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":76420.0,"shares_display":"76,420","price_per_share":26.3176809277676,"price_display":"26.32","price_state":"stated","total_value":2011197.1765,"total_display":"2,011,197.18","total_whole":"2,011,197","shares_owned_after":586812.0,"shares_owned_after_display":"586,812","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-17","filed_date":"2025-09-19","scope":"insider","n_lines":4},{"id":4356467,"accession":"0001396814-25-000109","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001396814-25-000109","line_url":"/filing/0001396814-25-000109#line-1","is_derivative":false,"issuer_cik":"0001396814","issuer_name":"Pacira BioSciences, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001396814","owner_cik":"0001722140","owner_name":"Ceesay Abraham","owner_display_name":"Ceesay Abraham","owner_url":"/insider/0001722140","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2354.0,"shares_display":"2,354","price_per_share":27.19,"price_display":"27.19","price_state":"stated","total_value":64005.26,"total_display":"64,005.26","total_whole":"64,005","shares_owned_after":9039.0,"shares_owned_after_display":"9,039","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-04","filed_date":"2025-09-08","scope":"insider"},{"id":6364869,"accession":"0000899243-22-030798","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-030798","line_url":"/filing/0000899243-22-030798#line-2","is_derivative":false,"issuer_cik":"0001722140","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001722140","owner_cik":"0001722140","owner_name":"Ceesay Abraham","owner_display_name":"Ceesay Abraham","owner_url":"/insider/0001722140","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19210.0,"shares_display":"19,210","price_per_share":32.5,"price_display":"32.50","price_state":"stated","total_value":624325.0,"total_display":"624,325.00","total_whole":"624,325","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-08","filed_date":"2022-09-12","scope":"insider"},{"id":6670479,"accession":"0000899243-22-029606","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-029606","line_url":"/filing/0000899243-22-029606#line-2","is_derivative":false,"issuer_cik":"0001722140","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001722140","owner_cik":"0001722140","owner_name":"Ceesay Abraham","owner_display_name":"Ceesay Abraham","owner_url":"/insider/0001722140","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9605.0,"shares_display":"9,605","price_per_share":32.5,"price_display":"32.50","price_state":"stated","total_value":312162.5,"total_display":"312,162.50","total_whole":"312,163","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-22","filed_date":"2022-08-24","scope":"insider"},{"id":6945061,"accession":"0000899243-22-028978","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-028978","line_url":"/filing/0000899243-22-028978#line-2","is_derivative":false,"issuer_cik":"0001722140","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001722140","owner_cik":"0001722140","owner_name":"Ceesay Abraham","owner_display_name":"Ceesay Abraham","owner_url":"/insider/0001722140","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9606.0,"shares_display":"9,606","price_per_share":34.12,"price_display":"34.12","price_state":"stated","total_value":327756.72,"total_display":"327,756.72","total_whole":"327,757","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-15","filed_date":"2022-08-17","scope":"insider"},{"id":6533133,"accession":"0000899243-22-028178","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-22-028178","line_url":"/filing/0000899243-22-028178","is_derivative":false,"issuer_cik":"0001722140","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001722140","owner_cik":"0001722140","owner_name":"Ceesay Abraham","owner_display_name":"Ceesay Abraham","owner_url":"/insider/0001722140","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19211.0,"shares_display":"19,211","price_per_share":38.624954453177864,"price_display":"38.62","price_state":"stated","total_value":742024.0,"total_display":"742,024.00","total_whole":"742,024","shares_owned_after":9605.0,"shares_owned_after_display":"9,605","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-08","filed_date":"2022-08-09","scope":"insider","n_lines":2},{"id":6533121,"accession":"0000899243-22-028178","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-028178","line_url":"/filing/0000899243-22-028178#line-2","is_derivative":false,"issuer_cik":"0001722140","issuer_name":"Cerevel Therapeutics Holdings, Inc.","issuer_ticker":"CERE","issuer_name_source":null,"issuer_url":"/issuer/0001722140","owner_cik":"0001722140","owner_name":"Ceesay Abraham","owner_display_name":"Ceesay Abraham","owner_url":"/insider/0001722140","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38424.0,"shares_display":"38,424","price_per_share":32.5,"price_display":"32.50","price_state":"stated","total_value":1248780.0,"total_display":"1,248,780.00","total_whole":"1,248,780","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-05","filed_date":"2022-08-09","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":42,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":42,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":42},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0002012593","name":"Rapport Therapeutics, Inc.","url":"/issuer/0002012593","role":"Director, Officer (Chief Executive Officer)","n_filings":10,"first_seen":"2025-09-19","last_seen":"2026-08-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001396814","name":"Pacira BioSciences, Inc.","url":"/issuer/0001396814","role":"Director","n_filings":1,"first_seen":"2025-09-08","last_seen":"2025-09-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001805387","name":"Cerevel Therapeutics Holdings, Inc.","url":"/issuer/0001805387","role":"Officer (President)","n_filings":4,"first_seen":"2022-08-09","last_seen":"2022-09-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001722140","retrieved_at":"2026-08-27T00:04:34+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}